Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 1186 AL 1200

The emerging role of polo-like kinase 2 in Alzheimer's disease

Martínez-Drudis L, Sheta R, Musiol D, Teixeira M, Oueslati A.

Exp Neurol. 2026 May 8;403:115806. doi: 10.1016/j.expneurol.2026.115806. Online ahead of print.

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease

Niziński P, Szalast K, Makuch-Kocka A, Paruch-Nosek K, Ciechanowska M, Plech T.

Molecules. 2026 Jan 16;31(2):320. doi: 10.3390/molecules31020320.

Impact of Alzheimer's Disease Co-Pathology on Shunt Outcomes in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review and Meta-Analysis

Patwardhan A, Sharafkhah M, Borrie M, Bhangu J.

Mov Disord. 2026 May 4. doi: 10.1002/mds.70333. Online ahead of print.

The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential

Shu D, Fu C, Liu Z, Li C.

FEBS J. 2026 May 6. doi: 10.1111/febs.70574. Online ahead of print.

Alzheimer's disease: disrupted communication between the endoplasmic reticulum and mitochondria

Guo J, Yang Z, Luo S, Li C, Xu S.

J Neurol. 2026 Apr 20;273(5):283. doi: 10.1007/s00415-026-13822-0.

The Potential of Exhaled Breath Analysis for Alzheimer's Disease Monitoring (mini review)

Patsiris S, Exarchos T, Vlamos P.

Adv Exp Med Biol. 2026;1487:129-140. doi: 10.1007/978-3-032-03398-7_15.

Wernicke's encephalopathy unmasking progressive supranuclear palsy and Alzheimer's pathology: a diagnostic challenge in an older adult

Defalque I, Ribeiro Da Costa R, Scheffler M, Mendes A.

BMJ Case Rep. 2026 Jan 6;19(1):e269430. doi: 10.1136/bcr-2025-269430.

Phytoconstituents as Potential Therapeutics against Enzymatic Targets for Neurodegenerative Diseases

Singh H, Pandey VP.

Curr Protein Pept Sci. 2026;27(1):46-65. doi: 10.2174/0113892037350938250514110643.

Resveratrol and the neuroinflammation axis in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia

Wang H, Li F, Wang H, Tian Z, Fan H, Shi Z.

Front Immunol. 2026 Apr 21;17:1758356. doi: 10.3389/fimmu.2026.1758356. eCollection 2026.

Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques

Kakkar A, Singh H, Anand A, Chopra H, Mishra AK.

Curr Pharm Des. 2026;32(7):493-504. doi: 10.2174/0113816128373290250620054118.

The Ubiquitin-proteasome system in neuroinflammation and neurodegeneration: Molecular insights and therapeutic avenues

Guo Y, Wang N, Tao Z, Huang X, Yu W, Zeng J, Liu X, Chen S, Hua F, Wang X.

Int Immunopharmacol. 2026 Jun 15;179:116599. doi: 10.1016/j.intimp.2026.116599. Epub 2026 Apr 11.

Epidemiological burden of Alzheimer's and Parkinson's diseases in East Asia: A comparative review of global burden of disease estimates and national registry data

Fan SP, Liu PC, Wang JZ, Win NN, Lin CH, Lin HH.

J Formos Med Assoc. 2026 Mar 20:S0929-6646(26)00242-1. doi: 10.1016/j.jfma.2026.03.072. Online ahead of print.

A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease

Ramanan S, Johnson GVW.

J Mol Neurosci. 2026 Apr 2;76(2):57. doi: 10.1007/s12031-026-02514-z.

[Acteoside: neurobiological activity spectrum, potential in the treatment of age-associated neurodegenerative diseases]

Berezutsky MA, Andronova TA, Belonogova YV, Durnova NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):41-47. doi: 10.17116/jnevro202612604141.

Protein S-sulfhydration: Mechanisms and therapeutic implications in Alzheimer's disease and Parkinson's disease

Guo J, Shi C, Yu C, Wang Y, He M.

Free Radic Biol Med. 2026 Mar 16;246:431-441. doi: 10.1016/j.freeradbiomed.2026.01.033. Epub 2026 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias